Skip Nav Destination
Article navigation
January 01 2006
Creating Markets for Vaccines
Rachel Glennerster,
Rachel Glennerster
Executive Director of the Abdul Latif Jameel Poverty Action Lab
Search for other works by this author on:
Michael Kremer,
Michael Kremer
Gates Professor of Developing Societies in the Department of Economics at Harvard University and a Senior Fellow at the Brookings Institution
Search for other works by this author on:
Heidi Williams
Heidi Williams
PhD Student in Economics at Harvard University
Search for other works by this author on:
Rachel Glennerster
Executive Director of the Abdul Latif Jameel Poverty Action Lab
Michael Kremer
Gates Professor of Developing Societies in the Department of Economics at Harvard University and a Senior Fellow at the Brookings Institution
Heidi Williams
PhD Student in Economics at Harvard University
Online ISSN: 1558-2485
Print ISSN: 1558-2477
© 2006 Tagore LLC
2006
Innovations: Technology, Governance, Globalization (2006) 1 (1): 67–79.
Citation
Rachel Glennerster, Michael Kremer, Heidi Williams; Creating Markets for Vaccines. Innovations: Technology, Governance, Globalization 2006; 1 (1): 67–79. doi: https://doi.org/10.1162/itgg.2006.1.1.67
Download citation file:
Email alerts
Advertisement
Cited By
Related Articles
Ending an Epidemic: The International AIDS Vaccine Initiative Pioneers a Public-Private Partnership
Innovations: Technology, Governance, Globalization (January,2006)
Optimal Vaccine Subsidies for Epidemic Diseases
The Review of Economics and Statistics (July,2024)
Public Misunderstanding of Science? Reframing the Problem of Vaccine Hesitancy
Perspectives on Science (September,2016)
Recommending research articles to consumers of online vaccination information
Quantitative Science Studies (June,2020)
Related Book Chapters
Vaccines
Viruses, Pandemics, and Immunity
A New Vaccine
Ending Epidemics: A History of Escape from Contagion
Race to the Vaccine
Ending Epidemics: A History of Escape from Contagion
Aerosol Vaccines
Innovation, Dual Use, and Security: Managing the Risks of Emerging Biological and Chemical Technologies